Logo image of AYX

Alteryx Inc (AYX) Stock Fundamental Analysis

NYSE:AYX - New York Stock Exchange, Inc. - US02156B1035 - Common Stock - Currency: USD

48.26  +0.01 (+0.02%)

After market: 48.28 +0.02 (+0.04%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AYX. AYX was compared to 281 industry peers in the Software industry. AYX may be in some trouble as it scores bad on both profitability and health. AYX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year AYX was profitable.
In the past year AYX had a positive cash flow from operations.
AYX had negative earnings in 4 of the past 5 years.
Of the past 5 years AYX 4 years had a positive operating cash flow.
AYX Yearly Net Income VS EBIT VS OCF VS FCFAYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M

1.2 Ratios

AYX's Return On Assets of -9.36% is in line compared to the rest of the industry. AYX outperforms 50.36% of its industry peers.
Looking at the Return On Equity, with a value of -94.21%, AYX is doing worse than 74.10% of the companies in the same industry.
Industry RankSector Rank
ROA -9.36%
ROE -94.21%
ROIC N/A
ROA(3y)-13.68%
ROA(5y)-8.14%
ROE(3y)-107.39%
ROE(5y)-64.18%
ROIC(3y)N/A
ROIC(5y)N/A
AYX Yearly ROA, ROE, ROICAYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 86.44%, AYX belongs to the top of the industry, outperforming 93.88% of the companies in the same industry.
AYX's Gross Margin has been stable in the last couple of years.
AYX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y-1.01%
AYX Yearly Profit, Operating, Gross MarginsAYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

2

2. Health

2.1 Basic Checks

AYX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AYX has more shares outstanding
AYX has more shares outstanding than it did 5 years ago.
AYX has a worse debt/assets ratio than last year.
AYX Yearly Shares OutstandingAYX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
AYX Yearly Total Debt VS Total AssetsAYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that AYX is in the distress zone and has some risk of bankruptcy.
AYX has a Altman-Z score of 1.24. This is in the lower half of the industry: AYX underperforms 60.07% of its industry peers.
The Debt to FCF ratio of AYX is 47.62, which is on the high side as it means it would take AYX, 47.62 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AYX (47.62) is comparable to the rest of the industry.
AYX has a Debt/Equity ratio of 4.42. This is a high value indicating a heavy dependency on external financing.
AYX's Debt to Equity ratio of 4.42 is on the low side compared to the rest of the industry. AYX is outperformed by 86.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.42
Debt/FCF 47.62
Altman-Z 1.24
ROIC/WACCN/A
WACC8.56%
AYX Yearly LT Debt VS Equity VS FCFAYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

AYX has a Current Ratio of 1.45. This is a normal value and indicates that AYX is financially healthy and should not expect problems in meeting its short term obligations.
AYX has a Current ratio (1.45) which is in line with its industry peers.
AYX has a Quick Ratio of 1.45. This is a normal value and indicates that AYX is financially healthy and should not expect problems in meeting its short term obligations.
AYX has a Quick ratio (1.45) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45
AYX Yearly Current Assets VS Current LiabilitesAYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2142.86% over the past year.
The Earnings Per Share has been growing by 15.42% on average over the past years. This is quite good.
AYX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.42%.
The Revenue has been growing by 30.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2142.86%
EPS 3Y15.42%
EPS 5YN/A
EPS Q2Q%102.38%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y25.11%
Revenue growth 5Y30.77%
Sales Q2Q%16.57%

3.2 Future

Based on estimates for the next years, AYX will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.64% on average per year.
The Revenue is expected to grow by 17.39% on average over the next years. This is quite good.
EPS Next Y-10.23%
EPS Next 2Y8.99%
EPS Next 3Y6.08%
EPS Next 5Y19.64%
Revenue Next Year12.19%
Revenue Next 2Y12.05%
Revenue Next 3Y19.72%
Revenue Next 5Y17.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AYX Yearly Revenue VS EstimatesAYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AYX Yearly EPS VS EstimatesAYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

AYX is valuated quite expensively with a Price/Earnings ratio of 33.75.
AYX's Price/Earnings ratio is a bit cheaper when compared to the industry. AYX is cheaper than 76.62% of the companies in the same industry.
When comparing the Price/Earnings ratio of AYX to the average of the S&P500 Index (26.82), we can say AYX is valued slightly more expensively.
AYX is valuated quite expensively with a Price/Forward Earnings ratio of 37.59.
Based on the Price/Forward Earnings ratio, AYX is valued a bit cheaper than 65.11% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, AYX is valued at the same level.
Industry RankSector Rank
PE 33.75
Fwd PE 37.59
AYX Price Earnings VS Forward Price EarningsAYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

AYX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 134.14
EV/EBITDA N/A
AYX Per share dataAYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.99%
EPS Next 3Y6.08%

0

5. Dividend

5.1 Amount

No dividends for AYX!.
Industry RankSector Rank
Dividend Yield N/A

Alteryx Inc

NYSE:AYX (3/18/2024, 8:04:00 PM)

After market: 48.28 +0.02 (+0.04%)

48.26

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-06 2024-02-06/amc
Earnings (Next)04-25 2024-04-25/amc
Inst Owners0.23%
Inst Owner Change0%
Ins Owners2%
Ins Owner Change0%
Market Cap3.49B
Analysts67.37
Price Target51.6 (6.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)334.33%
Min EPS beat(2)44.89%
Max EPS beat(2)623.77%
EPS beat(4)4
Avg EPS beat(4)185.62%
Min EPS beat(4)28.76%
Max EPS beat(4)623.77%
EPS beat(8)8
Avg EPS beat(8)114.46%
EPS beat(12)12
Avg EPS beat(12)109.5%
EPS beat(16)15
Avg EPS beat(16)105.31%
Revenue beat(2)2
Avg Revenue beat(2)6.1%
Min Revenue beat(2)2.94%
Max Revenue beat(2)9.26%
Revenue beat(4)3
Avg Revenue beat(4)3.25%
Min Revenue beat(4)-1.47%
Max Revenue beat(4)9.26%
Revenue beat(8)7
Avg Revenue beat(8)6.12%
Revenue beat(12)10
Avg Revenue beat(12)5.66%
Revenue beat(16)14
Avg Revenue beat(16)5.16%
PT rev (1m)0%
PT rev (3m)1.05%
EPS NQ rev (1m)4.91%
EPS NQ rev (3m)23.52%
EPS NY rev (1m)8.66%
EPS NY rev (3m)8.69%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)0.74%
Valuation
Industry RankSector Rank
PE 33.75
Fwd PE 37.59
P/S 3.6
P/FCF 134.14
P/OCF 120.27
P/B 18.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.43
EY2.96%
EPS(NY)1.28
Fwd EY2.66%
FCF(TTM)0.36
FCFY0.75%
OCF(TTM)0.4
OCFY0.83%
SpS13.42
BVpS2.63
TBVpS-3.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.36%
ROE -94.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.44%
FCFM 2.68%
ROA(3y)-13.68%
ROA(5y)-8.14%
ROE(3y)-107.39%
ROE(5y)-64.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y-1.01%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 4.42
Debt/FCF 47.62
Debt/EBITDA N/A
Cap/Depr 8.33%
Cap/Sales 0.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z 1.24
F-Score5
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)90.56%
Cap/Depr(5y)125.53%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2142.86%
EPS 3Y15.42%
EPS 5YN/A
EPS Q2Q%102.38%
EPS Next Y-10.23%
EPS Next 2Y8.99%
EPS Next 3Y6.08%
EPS Next 5Y19.64%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y25.11%
Revenue growth 5Y30.77%
Sales Q2Q%16.57%
Revenue Next Year12.19%
Revenue Next 2Y12.05%
Revenue Next 3Y19.72%
Revenue Next 5Y17.39%
EBIT growth 1Y40.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y120.24%
FCF growth 3Y-18.72%
FCF growth 5Y6.08%
OCF growth 1Y127.66%
OCF growth 3Y-27.08%
OCF growth 5Y2.14%